Interview with Dr. Aubrey de Grey, founder of SENS
Watch my fast-paced interview with Dr. Aubrey de Grey, Chief Science Officer of the SENS Research Foundation. SENS is the Strategies for Engineered Negligible Senescence.
Watch my fast-paced interview with Dr. Aubrey de Grey, Chief Science Officer of the SENS Research Foundation. SENS is the Strategies for Engineered Negligible Senescence.
Perhaps the loss of one’s own heartbeat will someday be as final as being tagged out by Yogi Berra at the plate.
DISCLAIMER: This website is for educational purposes only and is not for advertising. Telomerase activators and nanovesicles are not FDA-approved to prevent or treat any disease and anecdotes are not scientific proof of efficacy. All patients were treated in the context of a fully informed and legally-protected patient physician relationship.
Required fields
© 2020 Recharge Biomedical
Exosomes and TA-65 are not FDA-approved to prevent or treat any illness